Total assets · 2013–2025
Ultragenyx Pharmaceutical total assets
$1.5B+1.9% · FY2025
Ultragenyx Pharmaceutical (RARE) reported $1.5B in total assets for fiscal 2025, +1.9% year on year.
| Fiscal year | Total assets | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $1.5B | +1.9% | Open → |
| FY20242024-12-31 | $1.5B | +0.8% | Open → |
| FY20232023-12-31 | $1.5B | −3.5% | Open → |
| FY20222022-12-31 | $1.5B | +1.5% | Open → |
| FY20212021-12-31 | $1.5B | −13.5% | Open → |
| FY20202020-12-31 | $1.8B | +55.0% | Open → |
| FY20192019-12-31 | $1.1B | +57.8% | Open → |
| FY20182018-12-31 | $720M | +46.6% | Open → |
| FY20172017-12-31 | $491M | −9.2% | Open → |
| FY20162016-12-31 | $541M | −3.4% | Open → |
| FY20152015-12-31 | $560M | +182.7% | Open → |
| FY20142014-12-31 | $198M | +231.9% | Open → |
| FY20132013-12-31 | $59.6M | — | Open → |
Total assets — Total assets is everything the company owns at the balance-sheet date. Banks and insurers dominate this measure because customer deposits and policy reserves sit on their balance sheets.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2013–2025 compound annual growth +31.1%
Total assets at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Ultragenyx Pharmaceutical total assets |url=https://companiesranked.com/en/company/ultragenyx-pharmaceutical/total-assets |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Ultragenyx Pharmaceutical total assets. CompaniesRanked. https://companiesranked.com/en/company/ultragenyx-pharmaceutical/total-assetsBibTeX
@misc{companiesranked-en-company-ultragenyx-pharmaceutical-total-assets-2026,
author = {{CompaniesRanked}},
title = {{Ultragenyx Pharmaceutical total assets}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/ultragenyx-pharmaceutical/total-assets}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001193125-26-333233 · August 5, 2026
{{cite web |title=Ultragenyx Pharmaceutical total assets — 10-Q (0001193125-26-333233) |url=https://www.sec.gov/Archives/edgar/data/1515673/000119312526333233/rare-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.